Global Osteogenesis Imperfecta Pipeline Review 2017 - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Osteogenesis Imperfecta - Pipeline Review, H1 2017" report to their offering.

This report provides comprehensive information on the therapeutic development for Osteogenesis Imperfecta , complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Osteogenesis Imperfecta and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Key Topics Covered:

  1. Introduction
  2. Osteogenesis Imperfecta Overview
  3. Therapeutics Development
  4. Pipeline Products for Osteogenesis Imperfecta - Overview
  5. Pipeline Products for Osteogenesis Imperfecta - Comparative Analysis
  6. Osteogenesis Imperfecta - Therapeutics under Development by Companies
  7. Osteogenesis Imperfecta - Therapeutics under Investigation by Universities/Institutes
  8. Osteogenesis Imperfecta Products Glance
  9. Late Stage Products
  10. Clinical Stage Products
  11. Early Stage Products
  12. Osteogenesis Imperfecta - Products under Development by Companies
  13. Osteogenesis Imperfecta - Products under Investigation by Universities/Institutes
  14. Osteogenesis Imperfecta - Companies Involved in Therapeutics Development
  • Amgen Inc
  • Bone Therapeutics SA
  • Genzyme Corp
  • Mereo Biopharma Group Plc

For more information about this report visit http://www.researchandmarkets.com/research/dpbphs/osteogenesis

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Musculoskeletal Disorders Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Musculoskeletal Disorders Drugs